Epitel, Inc.
PrivateLast Round
Series B
Jul 28, 2026
Est. Valuation
$88M
Total Funding Raised
$53.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Epitel, Inc. is a digital health company that develops and commercializes wearable, wireless electroencephalogram (EEG) monitoring technology for seizure detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epitel, Inc. Comparables
Compare Epitel, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zeto, Inc. | 91% | |
| Ceribell | 80% | |
| NeuroServo | 79% |
Epitel, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 28, 2026 | ||||
| Series A | Feb 16, 2022 | ||||
| Grant | Feb 15, 2022 | ||||
| Seed | Dec 16, 2019 | ||||
| Grant | Jan 25, 2017 |
Key People
Founding team and executive leadership
Epitel, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ideaship | Seed |
| NIH RADx | Grant |
| OSF Ventures | Series A |
| Dexcom Ventures | Series A |
| Genoa Ventures | Series B, Series A |
| Wavemaker Three-Sixty Health | Series A |
| Epilepsy Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 106% MoM, reaching 6K.
- Jul 28, 2026
$26M round led by Catalyst Health Ventures and Genoa Ventures.
Recent news
Latest coverage and updates
- receives_financingJul 28, 2026
Epitel received financing of $26M in Series B on Jul 28th '26.
Epitel, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Epitel, Inc.'s valuation, stock price, and market status.
Is Epitel, Inc. a public or private company?
Epitel, Inc. is a private company.
What is the current stock price of Epitel, Inc.?
Epitel, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Epitel, Inc. worth (valuation)?
Valuation information for Epitel, Inc. is not publicly available.
Can I buy Epitel, Inc. stock?
Epitel, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Epitel, Inc.'s last funding round?
Epitel, Inc.'s most recent funding round was Series A on February 16, 2022.
Who are the main investors in Epitel, Inc.?
Key investors in Epitel, Inc. include Ideaship, Genoa Ventures, Catalyst Health Ventures.
Will Epitel, Inc. IPO soon?
No public IPO plans have been announced for Epitel, Inc..
How can I track Epitel, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epitel, Inc.'s secondary market activity and sign up for updates.